capecitabine plus oxaliplatin

DRUG2 trials

Sponsors

Guangdong Provincial People's Hospital, Fudan University

Conditions

Colorectal CancerPotentially Resectable Liver Metastasis From CRC

Phase 2

Evaluate Efficacy and Safety of XELOX in Potentially Resectable Liver Metastasis From Colorectal Cancer(CRC)

Guangdong Provincial People's HospitalColorectal Cancer, Potentially Resectable Liver Metastasis From CRC

Start: 2009-11-30End: 2015-10-31Target: 110Updated: 2009-10-19

Efficacy and Safety of Oxaliplatin Combined With Capecitabine as Neoadjuvant Chemotherapy for Locally Advanced Colon Cancer Patients

Fudan UniversityColorectal Cancer

Start: 2014-11-30Target: 55Updated: 2015-04-14

Related Papers

CapeOX perioperative chemotherapy versus postoperative chemotherapy for locally advanced resectable colon cancer: protocol for a two-period randomised controlled phase III trial

BMJ Open2019-01-0112 citations

CapOX as neoadjuvant chemotherapy for locally advanced operable colon cancer patients: a prospective single-arm phase II trial.

2016-12-0138 citations

Neoadjuvant chemotherapy with XELOX regimen for locally advanced operable colon cancer patients: a prospective phase II trial (NCT02415829).

Journal of Clinical Oncology2016-05-201 citations

Efficacy and safety of capecitabine plus oxaliplatin (XELOX) as the perioperative treatment of patients with potentially resectable liver-only metastases from colorectal cancer: A single arm, open-label, multicenter phase II trial (ML22298; NCT00997685).

Journal of Clinical Oncology2015-01-20